Detalhe da pesquisa
1.
Steatotic Liver Disease: Pathophysiology and Emerging Pharmacotherapies.
Pharmacol Rev
; 76(3): 454-499, 2024 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38697855
2.
The Effects of Sodium-Glucose Cotransporter 2-Inhibitors on Steatosis and Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease or Steatohepatitis and Type 2 Diabetes: A Systematic Review of Randomized Controlled Trials.
Medicina (Kaunas)
; 59(6)2023 Jun 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37374340
3.
Maturity-onset diabetes of the young (MODY) - in search of ideal diagnostic criteria and precise treatment.
Prog Cardiovasc Dis
; 2024 Mar 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38513726
4.
Health-Related Quality of Life Assessment in Older Patients with Type 1 and Type 2 Diabetes.
Healthcare (Basel)
; 11(15)2023 Jul 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37570394
5.
No Indices of Increased Type 2 Diabetes Risk in Individuals with Reactive Postprandial Hypoglycemia.
Metabolites
; 12(12)2022 Dec 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36557270
6.
Glucagon-Like Peptide-1 Receptor Agonists and Dual Glucose-Dependent Insulinotropic Polypeptide/Glucagon-Like Peptide-1 Receptor Agonists in the Treatment of Obesity/Metabolic Syndrome, Prediabetes/Diabetes and Non-Alcoholic Fatty Liver Disease-Current Evidence.
J Cardiovasc Pharmacol Ther
; 27: 10742484221146371, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36546652
7.
Acceptability of Continuous Glucose Monitoring in Elderly Diabetes Patients Using Multiple Daily Insulin Injections.
Diabetes Technol Ther
; 21(10): 566-574, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31335199
8.
Recent research advances in metabolism, clinical and experimental.
Metabolism
; 149: 155722, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37931873